(Yicai) July 23 -- Shanghai has formed three fund of funds to invest in the eastern Chinese city’s forerunner industries: artificial intelligence, biomedicine, and integrated circuits.

The three FOF, with a total initial capital of CNY89 billion (USD12.2 billion), will be managed by Shanghai SDIC Leading Private Equity Fund Management, according to data from corporate information platform Tianyancha.

Large investment institutions Shanghai Guojing Investment Development, Shanghai State-Owned Capital Investment, Guotai Junan Zhengyu Investment, and Haitong Innovation Securities Investment have invested in all three FOF.

Shanghai SDIC Leading AI Private Equity Investment Fund has an initial capital of CNY22.5 billion and will invest in AI-related fields, such as intelligent chips, smart software, autonomous driving, and intelligent robots.

With an initial capital of CNY21.5 billion, Shanghai SDIC Leading Biomedical Private Equity Investment Fund will invest in innovative drugs, high-end medical devices, biotechnology, high-end pharmaceutical equipment, and other biomedicine-related fields.

Shanghai SDIC Leading IC Private Equity Investment Fund, with an initial capital of CNY45 billion, will invest in IC-related fields, such as IC design, manufacturing, and sealing, as well as equipment materials and parts.

The establishment of the three FOF shows Shanghai’s determination to support new quality productive forces through venture capital, which is expected to attract dynamic funds, an equity investment expert told Yicai.

New quality productive forces refer to high-tech, high-efficiency, and high-quality productivity forces other than traditional economic growth modes and productivity development paths.

Editor: Futura Costaglione